Intelligence / Healthtech / FDA 510(k) Clearances / Gmp Medicare Sdn. Bhd.
Gmp Medicare Sdn. Bhd.
8 Sept 2026: Device cleared · Nitrile Powder Free Examination Glove, Blue Tested for Use with 32 Chemotherapy Drugs and Fentanyl Permeation Resistance Claim; Nitrile Powder Free Examination Glove, Violet Blue Tested for Use with 32 Chemotherapy Drugs, Xylazine, Fentanyl & Gastric Acid. Recorded in the openFDA device 510(k) data.
- Decided
- 8 Sept 2026
- Device
- Nitrile Powder Free Examination Glove, Blue Tested for Use with 32 Chemotherapy Drugs and Fentanyl Permeation Resistance Claim; Nitrile Powder Free Examination Glove, Violet Blue Tested for Use with 32 Chemotherapy Drugs, Xylazine, Fentanyl & Gastric Acid
- Specialty
- General Hospital
- Country
- Malaysia
- Location
- Klang
- Clearance type
- Special
- 510(k) number
- K260312
- Submitted
- 2026-01-30
A clearance starts commercialisation: distribution, reimbursement, software and sales hires.
- 268 added in the 30 days to 9 Nov 2026.
- Cardiovascular leads with 122 clearances, then Radiology (107).
Find the decision makers at Gmp Medicare Sdn. Bhd.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
More in General Hospital
FDA 510(k) Clearances
Source: openFDA device 510(k) data, data to 9 Nov 2026. Devices FDA found substantially equivalent and cleared for the US market. Decision dates as published by FDA. AOS shows what the public record says; it does not verify or endorse the company.